APMD
Apnimed, Inc.
NASDAQ · Healthcare · Biotechnology · US
$29.00
+3.17%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$0.49
- Revenue estimate
- —
Latest reported
- Last report date
- Sep 8, 2026
- EPS actual
- $3.92
- EPS estimate
- -$0.49
- Revenue actual
- $12.1M
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +905.5%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 8, 2026 | -$0.49 | $3.92 | Beat 905.47% | $12.1M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026